Antiplasmin Activity of a Peptide That Binds to the Receptor-binding Site of Angiogenin*
Antiplasmin Activity of a Peptide That Binds to the Receptor-binding Site of Angiogenin*
复制标题
与血管生成素受体结合位点结合的肽的抗纤溶酶活性*
DOI:
10.1074/jbc.m105526200
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
C. Chae
中科院分区:
文献类型:
--
作者:
Y. Gho;W. Yoon;C. Chae
It has been suggested that angiogenin binds to an actin-like molecule present on the surface of endothelial cells. Actin inhibits plasmin activity, but the angiogenin-actin complex is not active. In this report, we found that plasmin inhibits the interaction between angiogenin and actin suggesting a possibility that both angiogenin and plasmin may bind to a similar site on actin. Here we report that chANG, an antiangiogenin peptide that binds to the actin-binding site of angiogenin, inhibits the proteolytic activity of plasmin without any apparent effect on the activities of plasminogen activators and matrix metalloproteases. Its antiplasmin activity is comparable with that of actin. chANG inhibits plasmin activity via its binding to plasmin kringle domains while scrambled chANG does not bind to plasmin. chANG also inhibits the invasion of angiogenin-secreting human fibrosarcoma and colorectal carcinoma cells without effecting migration. Furthermore, chANG blocks angiogenesis induced by fibrosarcoma cells and metastasis of colorectal carcinoma cells to the liver. Therefore, the 11-amino acid peptide chANG has both antiangiogenin and antiplasmin activity, and could be useful in the development of anticancer agents.
影响因子:
15.9
作者:
BRESALIER, RS;NIV, Y;KIM, YS
通讯作者:
KIM, YS